Analyst picks & changes

Magainin Pharmaceuticals Inc.

Hambrecht & Quist analyst Timothy Wilson downgraded Magainin Pharmaceuticals Inc. to "hold" from "buy" until the uncertainty over the development of MSI-78 is resolved. MAGN announced last

Read the full 292 word article

How to gain access

Continue reading with a
two-week free trial.